Economic evaluation of alemtuzumab compared with natalizumab in the treatment of relapsing remitting multiple sclerosis in Colombia

MLA

Rodriguez Rincón, Angela Johanna, and Saidi Adriana Osorio Casalini. Economic Evaluation of Alemtuzumab Compared with Natalizumab in the Treatment of Relapsing Remitting Multiple Sclerosis in Colombia. Nov. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3056..d0509aa99ffd294e6da71ca706f2bf6e&authtype=sso&custid=ns315887.

APA

Rodriguez Rincón, A. J., & Osorio Casalini, S. A. (2020). Economic evaluation of alemtuzumab compared with natalizumab in the treatment of relapsing remitting multiple sclerosis in Colombia.

Chicago

Rodriguez Rincón, Angela Johanna, and Saidi Adriana Osorio Casalini. 2020. “Economic Evaluation of Alemtuzumab Compared with Natalizumab in the Treatment of Relapsing Remitting Multiple Sclerosis in Colombia,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3056..d0509aa99ffd294e6da71ca706f2bf6e&authtype=sso&custid=ns315887.